Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 13 - Jul 18
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Glutanex Lip Glow Balm Soft Scarlet RediClinic Glutathione Supplement: 100% Pure Japanese Glutathione with Vitamin C for Radiant Skin Amazon.com: Luma Nutrition Suplemento premium de glutatin 500 mg L glutatin Soporte antioxidante Reducido Soporte heptico 60 cpsulas : Todo lo dems Japan's Beauty Secret: Neocell Super Collagen Biotin & Vitamin C with Glutathione 250 Tablets Lazada Philippines Amazon.com: ESTHER FORMULA Liposomal Glutathione Strips (90 ct) Glutathione Direct, Antioxidant Support, Skin Glow Support, Sublingual Fast Absorbing Oral Strips, Korean Supplements : Health & Household Brightening IV Drip Markham Toronto SereneCosmeticClinic
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.3 ★★★★★
Based on 2249 reviews
Sort
Product Reviews
★★★★★ 5
For law students
Format: Paperback
Great resource for literal thinkers entering law school.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 25, 2024
★★★★★ 3
Needs to be more concise to weed out extraneous crap in your arguments
Format: Paperback
It’s very wordy and could be a lot more concise and be even more effective. “Getting to maybe” is not an exercise in dissertations but finding the right points to create an effective argument. There are better resources out there.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 25, 2026
★★★★★ 2
This book made me angry
Format: Paperback
I was excited about this book. Many law-related blogs and forums highly recommended this book. It's a "must read" for law students, they said.
I was angry when I read the introduction. I was angrier when I began reading the chapters. What happened to brevity? Law students are already swamped with course readings. Why write a book intended to be read by law students in such a long and voluminous way? Much of the text can be removed.
"Get to the point," I found myself telling the author as I read page after page. I hated it. It is the rare law student who will pick up this book for its narrative value. The typical law student will pick this book for its value on navigating through law school exams, not for its story-telling. Yet that student will be left disappointed.
I wish the author would have considered writing a "Get to the Point" book, which would serve as a shorter version of 'Getting to Maybe.' Perhaps it is not too late. "Get to the Point" could serve as an alternative or accompanying version, maybe? I ask that the author considers this.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 2, 2025
★★★★★ 5
Great overview!
Format: Paperback
Well worth the price for basic overview of Employment Law. Wish there was more information on co-employment risk.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 31, 2023
★★★★★ 5
Incredibly Helpful for an Employment Law Class
Format: Paperback
This book puts employment law in easy to understand terms. It really helped me condense everything I had learned over the course of the semester.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 19, 2021
recommand products
Microdosing Tirzepatide + Glycine Product Guide
25.02
compounded tirzepatide dosing chart Tirzepatide dosage chart for weight loss
21.33
https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound
27.81
Lilly's tirzepatide wins FDA approval for type 2 diabetes
24.83
Tirzepatide Instructions
22.69